Cargando…
A Review of the Currently Available Antibody Therapy for the Treatment of Coronavirus Disease 2019 (COVID-19)
Monoclonal antibodies are a promising treatment for COVID-19. However, the emergence of SARS-CoV-2 variants raised concerns about these therapies’ efficacy and long-term viability. Studies reported several antibodies, that received authorization for COVID-19 treatment, are not effective against new...
Autores principales: | Widyasari, Kristin, Kim, Jinnam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887598/ https://www.ncbi.nlm.nih.gov/pubmed/36648889 http://dx.doi.org/10.3390/antib12010005 |
Ejemplares similares
-
Rapid Antigen Tests during the COVID-19 Era in Korea and Their Implementation as a Detection Tool for Other Infectious Diseases
por: Widyasari, Kristin, et al.
Publicado: (2023) -
Currently available drugs for the treatment of Coronavirus-2
por: Anbarasan, T., et al.
Publicado: (2022) -
Current laboratory diagnostics of coronavirus disease 2019 (COVID-19)
por: Lippi, Giuseppe, et al.
Publicado: (2020) -
Current Insight into the Novel Coronavirus Disease 2019 (COVID-19)
por: Saxena, Shailendra K., et al.
Publicado: (2020) -
Monitoring Coronavirus Disease 2019: A Review of Available Diagnostic Tools
por: Liu, Shanshan, et al.
Publicado: (2021)